HT940825C0007

HEMATOLOGY COST PER REPORTABLE RESULT

Research the contractor View USAspending source Save to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

Field	Reported value
Agency	Department of Defense
Office	DEFENSE HEALTH AGENCY
NAICS	325413 — In-Vitro Diagnostic Substance Manufacturing
PSC	6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets
Parent award / vehicle	Not reported
Set-aside	NO SET ASIDE USED.
Pricing type	FIRM FIXED PRICE
Obligations	$196.9K
Current contract value	$196.9K
Potential contract value / ceiling	$590.7K
Start date	Apr 1, 2025
Current end date	Sep 30, 2026
Potential end date	Sep 30, 2029
Latest award activity	Dec 9, 2025
Source loaded	Sep 19, 2026

Funding and modification history

Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.

Date	Modification	Obligation change	Description
Dec 9, 2025	P00003	$131.3K	HEMATOLOGY COST-PER-REPORTABLE-RESULT
Aug 25, 2025	P00002	$0	THE KEESLER MEDICAL CENTER AT KEESLER AFB, MISSISSIPPI REQUIRES ONE (1) HEMATOLOGY SYSTEM WITH TWO (2) FUNCTIONING ANALYZERS, SLIDE MAKER STAINER, DIGITAL CELL MORPHOLOGY SYSTEM, WITH ADVANCED RED BLOOD CELL MORPHOLOGY SOFTWARE.
Mar 26, 2025	P00001	$65.6K	HEMATOLOGY COST PER REPORTABLE RESULT
Mar 12, 2025	0	$0	HEMATOLOGY COST PER REPORTABLE RESULT

Estimated positioning window

Sep 30, 2028 – Mar 30, 2029

Recompete signal:

60/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 60/100. Available recorded signals: 55 points.

Contract end 2029-09-30 (1064 days from calculation): +15 points
18 historical awards in this buyer and category group: +15 points
4 recorded award transactions: +10 points
Latest award action: 2025-12-09: +5 points
Parent award identifier recorded: +0 points
Solicitation identifier recorded: +10 points
Linked official forecast: +0 points
Calculated on: 2026-11-01 10:17:53.997580+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Nov 1, 2026.

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

Contact	Role	Published contact methods	Evidence	Source date
Carolynn Benn	Contact	carolynn.j.benn.civ@health.mil 2108684971	Source	Jan 31, 2025
David Erpelding	Contact	david.k.erpelding.civ@health.mil 210-269-4636	Source	Jan 31, 2025
Carolynn Benn	Contact	carolynn.j.benn.civ@health.mil 2108684971	Source	Jan 23, 2025
David Erpelding	Contact	david.k.erpelding.civ@health.mil 210-269-4636	Source	Jan 23, 2025
Carolynn Benn	Contact	carolynn.j.benn.civ@health.mil 2108684971	Source	Dec 20, 2024
David Erpelding	Contact	david.k.erpelding.civ@health.mil 210-269-4636	Source	Dec 20, 2024
Carolynn Benn	Contact	carolynn.j.benn.civ@health.mil 2108684971	Source	Dec 13, 2024
David Erpelding	Contact	david.k.erpelding.civ@health.mil 210-269-4636	Source	Dec 13, 2024
Carolynn Benn	Contact	carolynn.j.benn.civ@health.mil 2108684971	Source	Dec 13, 2024
David Erpelding	Contact	david.k.erpelding.civ@health.mil 210-269-4636	Source	Dec 13, 2024

Research next steps

Check the linked forecast or SAM for a confirmed solicitation and current timing.
Verify whether remaining options may extend performance beyond the current end date.
Check the stated set-aside against the solicitation and current certifications.
Review the award scope and buyer evidence before making a bid/no-bid decision.